Maria Antonello Ruffino shares insights from a cross-sectional survey that maps where consensus exists, where indications and planning thresholds diverge, and how geography and operator volume shape decision-making.
Maria Antonello Ruffino shares insights from a cross-sectional survey that maps where consensus exists, where indications and planning thresholds diverge, and how geography and operator volume shape decision-making.
LINC Today spoke with Dr Annabel Groenenberg about her team’s LAMARR concept, which aims to provide live intraoperative 3D tracking of stent-graft position from a single fluoroscopy image.
LINC Today spoke with Dr Annabel Groenenberg about her team’s LAMARR concept, which aims to provide live intraoperative 3D tracking of stent-graft position from a single fluoroscopy image.
In an interview with LINC Today regarding his presentation, Dr Armando Lobato set out a practical framework for decision-making in complicated acute type B and hybrid post-arch scenarios.
In an interview with LINC Today regarding his presentation, Dr Armando Lobato set out a practical framework for decision-making in complicated acute type B and hybrid post-arch scenarios.
Moritz Bischoff discusses how late failure modes and sac dynamics should shape risk-adapted surveillance, why patient engagement may be the decisive determinant of long-term safety, and how imaging strategies can be tailored.
Moritz Bischoff discusses how late failure modes and sac dynamics should shape risk-adapted surveillance, why patient engagement may be the decisive determinant of long-term safety, and how imaging strategies can be tailored.
Initiated in 2010, the Global Registry of Endovascular Aortic Treatment spans 14 countries and nearly 5,000 patients—with a wide spectrum of treatments reflecting real-world use.
Initiated in 2010, the Global Registry of Endovascular Aortic Treatment spans 14 countries and nearly 5,000 patients—with a wide spectrum of treatments reflecting real-world use.
Santi Trimarchi, MD,and Chiara Lomazzi, MD, presented the aims of the GREAT Registry, relaying its contemporary real-world data on aortic endografts in the treatment of multiple aortic pathologies.
Santi Trimarchi, MD,and Chiara Lomazzi, MD, presented the aims of the GREAT Registry, relaying its contemporary real-world data on aortic endografts in the treatment of multiple aortic pathologies.
Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio
LATHAM, N.Y.--Feb. 3, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on...
Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio
LATHAM, N.Y.--Feb. 3, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on...
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...
JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular
BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular
BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients.
FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients.
FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs.
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs.
Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled...
Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled...
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
